ITOS
$20.92
Iteos Therapeutics
$.77
3.82%
ITOS
Earnings Whisper ®
N/A
4th Quarter December 2022
Consensus:  $0.13
Revenue:  $41.16 Mil
Thursday
Feb 9
4:00 PM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when ITOS reports earnings?
Beat
Meet
Miss

Where is ITOS's stock price going from here?
Up
Flat
Down
Stock chart of ITOS
Analysts
Summary of analysts' recommendations for ITOS
Score
Grade
Pivots
Resistance
$22.73
$21.86
$21.39

$20.51

Support
$20.04
$19.17
$18.70
Tweet
Growth
Description
iTeos Therapeutics Inc. is a clinical-stage biopharmaceutical company. It engages in the discovery and development of immuno-oncology therapeutics. iTeos Therapeutics Inc. is based in Cambridge, United States.